Merck & Co <a href="https://www.reuters.com/companies/MRK.N" target="_blank">(MRK.N)</a> said on Sunday it will buy Prometheus Biosciences Inc <a href="https://www.reuters.com/companies/RXDX.O" target="_blank">(RXDX.O)</a> for about $10.8 billion, picking up …